Content Library
How Aldevron and Oxford Genetics have come together to advance CAR-T development.
James Brown,
VP Corporate Development,
Aldevron
White Paper: Advancing Next Generation Therapeutics
By Sartorius brands; IncuCyte & intellicyt
How to Generate Optimal-Affinity TCRs for the Clinic?
Elisa Kieback,
CEO,
T-Knife
Development of First Manufacturing Process to Produce CAR-Treg Cells for Clinical Use
Pierre Heimendinger,
VP Pharmaceutical Development,
TxCell
Regenerative Medicines and Cell Therapy Products: Is the NICE Therapy Products: Is the NICE Therapy
Grace Hampson,
Senior Economist
The Office of Health Economics